Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthijs M Jore

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Science (New York, N.Y.)|August 16, 2008
Small CRISPR RNAs guide antiviral defense in prokaryotesStan J J Brouns, Matthijs M Jore, Magnus Lundgren, et al.
Nature|February 18, 2014
DNA-guided DNA interference by a prokaryotic ArgonauteDaan C Swarts, Matthijs M Jore, Edze R Westra, et al.
Molecular & Cellular Proteomics : MCP|August 25, 2012
Native tandem and ion mobility mass spectrometry highlight structural and modular similarities in clustered-regularly-interspaced shot-palindromic-repeats (CRISPR)-associated protein complexes from Escherichia coli and Pseudomonas aeruginosaEsther van Duijn, Ioana M Barbu, Arjan Barendregt, et al.
Frontiers in Immunology|July 11, 2022
Heterologous Expression and Evaluation of Novel <i>Plasmodium falciparum</i> Transmission Blocking Vaccine CandidatesRoos M de Jong, Susheel K Singh, Karina Teelen, et al.
Nature Communications|September 22, 2018
Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibodyFrank Lennartz, Florian Brod, Rebecca Dabbs, et al.
NPJ Vaccines|October 13, 2021
Preclinical development of a Pfs230-Pfs48/45 chimeric malaria transmission-blocking vaccineSusheel K Singh, Jordan Plieskatt, Bishwanath K Chourasia, et al.
The Journal of Infectious Diseases|April 12, 2023
Modeling the Impact of a Highly Potent Plasmodium falciparum Transmission-Blocking Monoclonal Antibody in Areas of Seasonal Malaria TransmissionJoseph D Challenger, Stijn W van Beek, Rob Ter Heine, et al.
Molecular Microbiology|July 28, 2010
H-NS-mediated repression of CRISPR-based immunity in Escherichia coli K12 can be relieved by the transcription activator LeuOEdze R Westra, Umit Pul, Nadja Heidrich, et al.
Frontiers in Immunology|June 25, 2019
<i>Pf</i>s230 and <i>Pf</i>s48/45 Fusion Proteins Elicit Strong Transmission-Blocking Antibody Responses Against <i>Plasmodium falciparum</i>Susheel K Singh, Susan Thrane, Bishwanath K Chourasia, et al.
NPJ Vaccines|December 12, 2023
Pfs230 Domain 7 is targeted by a potent malaria transmission-blocking monoclonal antibodyMaartje R Inklaar, Roos M de Jong, Ezra T Bekkering, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Science (New York, N.Y.)|August 16, 2008
Small CRISPR RNAs guide antiviral defense in prokaryotesStan J J Brouns, Matthijs M Jore, Magnus Lundgren, et al.
Nature|February 18, 2014
DNA-guided DNA interference by a prokaryotic ArgonauteDaan C Swarts, Matthijs M Jore, Edze R Westra, et al.
Molecular & Cellular Proteomics : MCP|August 25, 2012
Native tandem and ion mobility mass spectrometry highlight structural and modular similarities in clustered-regularly-interspaced shot-palindromic-repeats (CRISPR)-associated protein complexes from Escherichia coli and Pseudomonas aeruginosaEsther van Duijn, Ioana M Barbu, Arjan Barendregt, et al.
Frontiers in Immunology|July 11, 2022
Heterologous Expression and Evaluation of Novel <i>Plasmodium falciparum</i> Transmission Blocking Vaccine CandidatesRoos M de Jong, Susheel K Singh, Karina Teelen, et al.
Nature Communications|September 22, 2018
Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibodyFrank Lennartz, Florian Brod, Rebecca Dabbs, et al.
NPJ Vaccines|October 13, 2021
Preclinical development of a Pfs230-Pfs48/45 chimeric malaria transmission-blocking vaccineSusheel K Singh, Jordan Plieskatt, Bishwanath K Chourasia, et al.
The Journal of Infectious Diseases|April 12, 2023
Modeling the Impact of a Highly Potent Plasmodium falciparum Transmission-Blocking Monoclonal Antibody in Areas of Seasonal Malaria TransmissionJoseph D Challenger, Stijn W van Beek, Rob Ter Heine, et al.
Molecular Microbiology|July 28, 2010
H-NS-mediated repression of CRISPR-based immunity in Escherichia coli K12 can be relieved by the transcription activator LeuOEdze R Westra, Umit Pul, Nadja Heidrich, et al.
Frontiers in Immunology|June 25, 2019
<i>Pf</i>s230 and <i>Pf</i>s48/45 Fusion Proteins Elicit Strong Transmission-Blocking Antibody Responses Against <i>Plasmodium falciparum</i>Susheel K Singh, Susan Thrane, Bishwanath K Chourasia, et al.
NPJ Vaccines|December 12, 2023
Pfs230 Domain 7 is targeted by a potent malaria transmission-blocking monoclonal antibodyMaartje R Inklaar, Roos M de Jong, Ezra T Bekkering, et al.
Pageof 5